\-\ Texto\\:\\ \ \(0\)\
\-\ none\\ given\ \(0\)\
\-\ treatment\\ depends\\ on\\ the\\ extent\\ of\\ colonic\\ inflammation\\,\\ severity\\ of\\ symptoms\\,\\ and\\ other\\ factors\\.1\\ mild\\ exacerbations\\ involving\\ inflammation\\ of\\ the\\ rectum\\ and\\ left\\ colon\\ are\\ treated\\ with\\ anti\\-inflammatory\\ agents\\ including\\ sulfasalazine\\ or\\ mesalamine\\.\\ acute\\ exacerbations\\ of\\ pancolitis\\ may\\ require\\ oral\\ steroids\\,\\ and\\ definitive\\ treatment\\ of\\ ulcerative\\ colitis\\ is\\ achieved\\ with\\ total\\ colectomy\\.\\ indications\\ for\\ surgeries\\ include\\ treatment\\ refractory\\ to\\ medication\\,\\ desire\\ for\\ definitive\\ treatment\\,\\ and\\ dysplasia\\ found\\ on\\ endoscopic\\ biopsy\\.\\ patients\\ with\\ ulcerative\\ colitis\\ are\\ at\\ increased\\ risk\\ for\\ colon\\ cancer\\,\\ and\\ require\\ close\\ observation\\ including\\ frequent\\ colonoscopies\\ although\\ the\\ timing\\ of\\ surveillance\\ is\\ controversial\\.2\\ american\\ gastroenterology\\ association\\ recommends\\ colonoscopies\\ 8\\ years\\ after\\ initial\\ diagnosis\\ of\\ pancolitis\\ and\\ 15\\ years\\ if\\ inflammation\\ is\\ confined\\ to\\ the\\ left\\ colon\\.\\ the\\ american\\ college\\ of\\ gastroenterology\\ recommends\\ colonoscopy\\ at\\ 8\\-10\\ years\\ after\\ diagnosis\\ in\\ surgical\\ candidates\\.\\ 2\ \(0\)\
\-\ double\\ contrast\\ barium\\ enema\\ with\\ prone\\ and\\ supine\\ views\\ indicating\\ shortening\\ of\\ the\\ colon\\ and\\ loss\\ of\\ haustral\\ folds\\ mimicking\\ a\\ lead\\ pipe\\.\\ areas\\ of\\ ulceration\\ of\\ the\\ mucosa\\ are\\ seen\\ from\\ rectum\\ to\\ cecum\\,\\ they\\ are\\ continuous\\ and\\ become\\ less\\ prominent\\ proximally\\.\\ contrast\\ is\\ seen\\ passing\\ through\\ the\\ ileocecal\\ valve\\.\\ the\\ appendix\\ was\\ not\\ seen\\.\ \(0\)\
\-\ ulcerative\\ colitis\ \(20\)\
\-\ ulcerative\\ colitis\\,\\ crohn\\â\\€\\™s\\ disease\ \(0\)\
\-\ 15\\ y\\/o\\ with\\ longstanding\\ history\\ of\\ cramping\\ abdominal\\ pain\\ and\\ bloody\\ diarrhea\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ulcerative\\:\\ 0\\.3019840317510699\ \(0\)\
\-\ colitis\\:\\ 0\\.2655833595173951\ \(0\)\
\-\ colonoscopies\\:\\ 0\\.214737577776166\ \(0\)\
\-\ colon\\:\\ 0\\.20448086826998726\ \(0\)\
\-\ pancolitis\\:\\ 0\\.19316875030617117\ \(0\)\
\-\ recommends\\:\\ 0\\.1852484348782476\ \(0\)\
\-\ exacerbations\\:\\ 0\\.17460902883178636\ \(0\)\
\-\ of\\:\\ 0\\.1708027353764926\ \(0\)\
\-\ gastroenterology\\:\\ 0\\.17067669534316976\ \(0\)\
\-\ inflammation\\:\\ 0\\.1618758243045146\ \(0\)\
\-\ and\\:\\ 0\\.13873311747153416\ \(0\)\
\-\ rectum\\:\\ 0\\.13547384600310866\ \(0\)\
\-\ treatment\\:\\ 0\\.1279261761479595\ \(0\)\
\-\ years\\:\\ 0\\.12346467435421982\ \(0\)\
\-\ definitive\\:\\ 0\\.12265135849274422\ \(0\)\
\-\ the\\:\\ 0\\.1205687472225645\ \(0\)\
\-\ require\\:\\ 0\\.1154133889184347\ \(0\)\
\-\ american\\:\\ 0\\.11456350297193348\ \(0\)\
\-\ are\\:\\ 0\\.10190375522580526\ \(0\)\
\-\ mesalamine\\:\\ 0\\.09921069483084433\ \(0\)\
\-\ pipe\\:\\ 0\\.09921069483084433\ \(0\)\
\-\ desire\\:\\ 0\\.09658437515308559\ \(0\)\
\-\ including\\:\\ 0\\.09609501914541116\ \(0\)\
\-\ seen\\:\\ 0\\.0948245316027163\ \(0\)\
\-\ sulfasalazine\\:\\ 0\\.0944385157300036\ \(0\)\
\-\ haustral\\:\\ 0\\.09105260077360566\ \(0\)\
\-\ mimicking\\:\\ 0\\.09105260077360566\ \(0\)\
\-\ 15\\:\\ 0\\.09073597018940863\ \(0\)\
\-\ candidates\\:\\ 0\\.08628042167276492\ \(0\)\
\-\ cramping\\:\\ 0\\.08533834767158488\ \(0\)\
\-\ timing\\:\\ 0\\.08446612338188512\ \(0\)\
\-\ college\\:\\ 0\\.08365410199500616\ \(0\)\
\-\ colectomy\\:\\ 0\\.0808718907423169\ \(0\)\
\-\ depends\\:\\ 0\\.07812232761552625\ \(0\)\
\-\ longstanding\\:\\ 0\\.07812232761552625\ \(0\)\
\-\ indications\\:\\ 0\\.07764186736084946\ \(0\)\
\-\ ileocecal\\:\\ 0\\.07764186736084946\ \(0\)\
\-\ shortening\\:\\ 0\\.07673606347108344\ \(0\)\
\-\ proximally\\:\\ 0\\.07589501705879301\ \(0\)\
\-\ achieved\\:\\ 0\\.07511008346716075\ \(0\)\
\-\ bloody\\:\\ 0\\.07511008346716075\ \(0\)\
\-\ passing\\:\\ 0\\.07437424125781376\ \(0\)\
\-\ refractory\\:\\ 0\\.0736817096468877\ \(0\)\
\-\ is\\:\\ 0\\.07354513970088696\ \(0\)\
\-\ surveillance\\:\\ 0\\.0733501485146855\ \(0\)\
\-\ ulceration\\:\\ 0\\.0733501485146855\ \(0\)\
\-\ folds\\:\\ 0\\.07240807451350546\ \(0\)\
\-\ confined\\:\\ 0\\.07181946977509975\ \(0\)\
\-\ prone\\:\\ 0\\.07181946977509975\ \(0\)\
\-\ surgeries\\:\\ 0\\.07125890469698282\ \(0\)\
\-\ continuous\\:\\ 0\\.07046514497682334\ \(0\)\
\-\ agents\\:\\ 0\\.07021202464404615\ \(0\)\
\-\ endoscopic\\:\\ 0\\.07021202464404615\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.06996423355828757\ \(0\)\
\-\ diagnosis\\:\\ 0\\.06960805790603893\ \(0\)\
\-\ cecum\\:\\ 0\\.06814993526740777\ \(0\)\
\-\ enema\\:\\ 0\\.06773692300155433\ \(0\)\
\-\ supine\\:\\ 0\\.0673379138805288\ \(0\)\
\-\ severity\\:\\ 0\\.06621614720057509\ \(0\)\
\-\ with\\:\\ 0\\.06573261152699232\ \(0\)\
\-\ colonic\\:\\ 0\\.06552361558964902\ \(0\)\
\-\ crohn\\:\\ 0\\.06535666751616988\ \(0\)\
\-\ contrast\\:\\ 0\\.06524227727771226\ \(0\)\
\-\ after\\:\\ 0\\.06513979873675704\ \(0\)\
\-\ mucosa\\:\\ 0\\.06471159420277005\ \(0\)\
\-\ indicating\\:\\ 0\\.06351871164578811\ \(0\)\
\-\ diarrhea\\:\\ 0\\.06351871164578811\ \(0\)\
\-\ observation\\:\\ 0\\.0629647439007136\ \(0\)\
\-\ medication\\:\\ 0\\.06205393058680747\ \(0\)\
\-\ frequent\\:\\ 0\\.06156345787568724\ \(0\)\
\-\ valve\\:\\ 0\\.06156345787568724\ \(0\)\
\-\ extent\\:\\ 0\\.06144396809973434\ \(0\)\
\-\ for\\:\\ 0\\.06104732809922435\ \(0\)\
\-\ close\\:\\ 0\\.06075143648880827\ \(0\)\
\-\ appendix\\:\\ 0\\.06052936118649176\ \(0\)\
\-\ association\\:\\ 0\\.06041987535660609\ \(0\)\
\-\ barium\\:\\ 0\\.05978352352699882\ \(0\)\
\-\ lead\\:\\ 0\\.05978352352699882\ \(0\)\
\-\ become\\:\\ 0\\.059578828944315654\ \(0\)\
\-\ double\\:\\ 0\\.059179819823290125\ \(0\)\
\-\ steroids\\:\\ 0\\.0589852758594677\ \(0\)\
\-\ total\\:\\ 0\\.05501134442615808\ \(0\)\
\-\ oral\\:\\ 0\\.05377128889284212\ \(0\)\
\-\ views\\:\\ 0\\.05299235155259513\ \(0\)\
\-\ prominent\\:\\ 0\\.05287696198286363\ \(0\)\
\-\ dysplasia\\:\\ 0\\.05142073488707699\ \(0\)\
\-\ at\\:\\ 0\\.05071798642566053\ \(0\)\
\-\ to\\:\\ 0\\.05035334396336503\ \(0\)\
\-\ risk\\:\\ 0\\.04797157613616349\ \(0\)\
\-\ they\\:\\ 0\\.04797157613616349\ \(0\)\
\-\ biopsy\\:\\ 0\\.04706156805208968\ \(0\)\
\-\ involving\\:\\ 0\\.04702659137898011\ \(0\)\
\-\ given\\:\\ 0\\.04618434072646359\ \(0\)\
\-\ left\\:\\ 0\\.04580469011681103\ \(0\)\
\-\ although\\:\\ 0\\.04570648178505621\ \(0\)\
\-\ less\\:\\ 0\\.04567530390764688\ \(0\)\
\-\ areas\\:\\ 0\\.04558226277617133\ \(0\)\
\-\ initial\\:\\ 0\\.0450389520780396\ \(0\)\
\-\ cancer\\:\\ 0\\.044718867925624954\ \(0\)\
\-\ found\\:\\ 0\\.043441553054260756\ \(0\)\
\-\ treated\\:\\ 0\\.04180892869657216\ \(0\)\
\-\ loss\\:\\ 0\\.040903124806806135\ \(0\)\
\-\ on\\:\\ 0\\.040553849781790316\ \(0\)\
\-\ through\\:\\ 0\\.03996584202972625\ \(0\)\
\-\ include\\:\\ 0\\.039946688824784214\ \(0\)\
\-\ if\\:\\ 0\\.039009032028324626\ \(0\)\
\-\ mild\\:\\ 0\\.03805880448207345\ \(0\)\
\-\ patients\\:\\ 0\\.03776897649500867\ \(0\)\
\-\ symptoms\\:\\ 0\\.03673428524432993\ \(0\)\
\-\ abdominal\\:\\ 0\\.036719727862338666\ \(0\)\
\-\ none\\:\\ 0\\.036690667003526106\ \(0\)\
\-\ acute\\:\\ 0\\.0363192639929225\ \(0\)\
\-\ increased\\:\\ 0\\.036305210687563906\ \(0\)\
\-\ other\\:\\ 0\\.034866007199661334\ \(0\)\
\-\ may\\:\\ 0\\.03378611936834152\ \(0\)\
\-\ surgical\\:\\ 0\\.032631413315928975\ \(0\)\
\-\ disease\\:\\ 0\\.02818228140652716\ \(0\)\
\-\ from\\:\\ 0\\.026664494124603304\ \(0\)\
\-\ not\\:\\ 0\\.02650461147382421\ \(0\)\
\-\ history\\:\\ 0\\.025650724723808218\ \(0\)\
\-\ pain\\:\\ 0\\.024024561484890156\ \(0\)\
\-\ was\\:\\ 0\\.023398369036008188\ \(0\)\
\-\ or\\:\\ 0\\.02335622585330244\ \(0\)\
\-\ in\\:\\ 0\\.016701834969554234\ \(0\)\
